AllianceBernstein
BVS icon

AllianceBernstein’s Bioventus BVS Stock Holding History

AllianceBernstein’s Portfolio BVS Stock Details BVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$302K Buy
33,070
+13,400
+68% +$128K ﹤0.01% 2984
2026
Q1 		$146K Hold
19,670
– – ﹤0.01% 3115
2025
Q4 		$146K Hold
19,670
– – ﹤0.01% 3123
2025
Q3 		$132K Hold
19,670
– – ﹤0.01% 3149
2025
Q2 		$130K Buy
19,670
+6,500
+49% +$46.1K ﹤0.01% 3134
2025
Q1 		$121K Hold
13,170
– – ﹤0.01% 3037
2024
Q4 		$138K Sell
13,170
-3,500
-21% -$41.4K ﹤0.01% 3089
2024
Q3 		$199K Buy
16,670
+5,210
+45% +$45K ﹤0.01% 3041
2024
Q2 		$65.9K Buy
+11,460
New +$62.9K ﹤0.01% 3169
2023
Q2 		– Sell
-48,669
Closed -$52.1K – 3179
2023
Q1 		$52.1K Hold
48,669
– – ﹤0.01% 3093
2022
Q4 		$127K Buy
48,669
+8,100
+20% +$35.4K ﹤0.01% 3090
2022
Q3 		$284K Buy
40,569
+5,000
+14% +$39.1K ﹤0.01% 2886
2022
Q2 		$243K Buy
35,569
+17,400
+96% +$178K ﹤0.01% 2951
2022
Q1 		$256K Hold
18,169
– – ﹤0.01% 2923
2021
Q4 		$263K Buy
+18,169
New +$258K ﹤0.01% 2986

Other funds holding BVS

EWM
Essex Woodlands Management The Woodlands, Texas $254M AUM 4.59% 1-Year Est. Return
JIC
Juniper Investment Company New York $378M AUM 95.37% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

AllianceBernstein's BVS Position: Q2 2026 in Review

AllianceBernstein increased its Bioventus (BVS) stake by 68% in Q2 2026, buying an estimated $128K and bringing the position to 33,070 shares worth $302K. The position accounts for ﹤0.01% of the portfolio, ranked #2984.

AllianceBernstein first reported a position in BVS in Q4 2021 and has held it in 15 quarters since. 157 funds tracked by Wall St. Rank hold BVS as of Q2 2026.

  • AllianceBernstein held 33,070 shares of Bioventus worth $302K as of Q2 2026.
  • AllianceBernstein bought 13,400 Bioventus shares in Q2 2026, an estimated $128K.
  • Bioventus made up ﹤0.01% of AllianceBernstein's portfolio in Q2 2026, its #2984 holding.
  • AllianceBernstein first reported a position in Bioventus in Q4 2021 and has held it in 15 quarters since.
  • 157 funds tracked by Wall St. Rank held Bioventus as of Q2 2026.

Based on AllianceBernstein's 13F filing for Q2 2026, filed 14 Aug 2026.